These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
342 related articles for article (PubMed ID: 12096249)
21. Endovascular aneurysm repair at 5 years: Does aneurysm diameter predict outcome? Zarins CK; Crabtree T; Bloch DA; Arko FR; Ouriel K; White RA J Vasc Surg; 2006 Nov; 44(5):920-29; discussion 929-31. PubMed ID: 17098519 [TBL] [Abstract][Full Text] [Related]
22. Prognostic and predictive biomarkers of abdominal aortic aneurysm growth rate. Deeg MA; Meijer CA; Chan LS; Shen L; Lindeman JH Curr Med Res Opin; 2016; 32(3):509-17. PubMed ID: 26636178 [TBL] [Abstract][Full Text] [Related]
23. Clinical trial of doxycycline for matrix metalloproteinase-9 inhibition in patients with an abdominal aneurysm: doxycycline selectively depletes aortic wall neutrophils and cytotoxic T cells. Lindeman JH; Abdul-Hussien H; van Bockel JH; Wolterbeek R; Kleemann R Circulation; 2009 Apr; 119(16):2209-16. PubMed ID: 19364980 [TBL] [Abstract][Full Text] [Related]
24. The influence of wall stress on AAA growth and biomarkers. Speelman L; Hellenthal FA; Pulinx B; Bosboom EM; Breeuwer M; van Sambeek MR; van de Vosse FN; Jacobs MJ; Wodzig WK; Schurink GW Eur J Vasc Endovasc Surg; 2010 Apr; 39(4):410-6. PubMed ID: 20060752 [TBL] [Abstract][Full Text] [Related]
25. Expansion of small-diameter abdominal aortic aneurysms is not reflected by the release of inflammatory mediators IL-6, MMP-9 and CRP in plasma. Karlsson L; Bergqvist D; Lindbäck J; Pärsson H Eur J Vasc Endovasc Surg; 2009 Apr; 37(4):420-4. PubMed ID: 19119028 [TBL] [Abstract][Full Text] [Related]
26. MMP-9: biomarker for abdominal aneurysm. Affirul CA; Azim IM; Hanafiah H; Nor Azmi K; Rozman Z Clin Ter; 2013; 164(6):e479-83. PubMed ID: 24424226 [TBL] [Abstract][Full Text] [Related]
27. In vivo optical molecular imaging of matrix metalloproteinase activity in abdominal aortic aneurysms correlates with treatment effects on growth rate. Sheth RA; Maricevich M; Mahmood U Atherosclerosis; 2010 Sep; 212(1):181-7. PubMed ID: 20542274 [TBL] [Abstract][Full Text] [Related]
28. Serum Calprotectin as a Novel Biomarker in Abdominal Aortic Aneurysm Pathogenesis and Progression: Preliminary Data from Experimental Model in Rats. Moris D; Theocharis S; Davakis S; Patelis N; Agrogiannis G; Vlachos IS; Spartalis E; Athanasiou A; Bakoyiannis C; Perrea DN; Georgopoulos S Curr Vasc Pharmacol; 2018 Jan; 16(2):168-178. PubMed ID: 28155626 [TBL] [Abstract][Full Text] [Related]
29. Doxycycline inhibition of abdominal aortic aneurysm growth: a systematic review of the literature. Dodd BR; Spence RA Curr Vasc Pharmacol; 2011 Jul; 9(4):471-8. PubMed ID: 21595625 [TBL] [Abstract][Full Text] [Related]
30. Doxycycline inhibition of aneurysmal degeneration in an elastase-induced rat model of abdominal aortic aneurysm: preservation of aortic elastin associated with suppressed production of 92 kD gelatinase. Petrinec D; Liao S; Holmes DR; Reilly JM; Parks WC; Thompson RW J Vasc Surg; 1996 Feb; 23(2):336-46. PubMed ID: 8637112 [TBL] [Abstract][Full Text] [Related]
31. Interference of doxycycline pretreatment in a model of abdominal aortic aneurysms. Mata KM; Tefé-Silva C; Floriano EM; Fernandes CR; Rizzi E; Gerlach RF; Mazzuca MQ; Ramos SG Cardiovasc Pathol; 2015; 24(2):110-20. PubMed ID: 25466491 [TBL] [Abstract][Full Text] [Related]
32. Pharmacologic suppression of experimental abdominal aortic aneurysms: acomparison of doxycycline and four chemically modified tetracyclines. Curci JA; Petrinec D; Liao S; Golub LM; Thompson RW J Vasc Surg; 1998 Dec; 28(6):1082-93. PubMed ID: 9845660 [TBL] [Abstract][Full Text] [Related]
34. Outcome of endovascular repair of small and large abdominal aortic aneurysms. Jim J; Rubin BG; Geraghty PJ; Criado FJ; Sanchez LA Ann Vasc Surg; 2011 Apr; 25(3):306-14. PubMed ID: 21396566 [TBL] [Abstract][Full Text] [Related]
35. Growth rates of small abdominal aortic aneurysms assessed by computerised tomography--a systematic literature review. Hendy K; Gunnarson R; Golledge J Atherosclerosis; 2014 Jul; 235(1):182-8. PubMed ID: 24848928 [TBL] [Abstract][Full Text] [Related]
36. Late abdominal aortic aneurysm enlargement after endovascular repair with the Excluder device. Cho JS; Dillavou ED; Rhee RY; Makaroun MS J Vasc Surg; 2004 Jun; 39(6):1236-41; discussion 2141-2. PubMed ID: 15192562 [TBL] [Abstract][Full Text] [Related]
38. Size matters: the relationship between MMP-9 expression and aortic diameter. McMillan WD; Tamarina NA; Cipollone M; Johnson DA; Parker MA; Pearce WH Circulation; 1997 Oct; 96(7):2228-32. PubMed ID: 9337194 [TBL] [Abstract][Full Text] [Related]
39. Matrix metalloproteinases in the aneurysm wall of patients treated with low-dose doxycycline. Ding R; McGuinness CL; Burnand KG; Sullivan E; Smith A Vascular; 2005; 13(5):290-7. PubMed ID: 16288704 [TBL] [Abstract][Full Text] [Related]
40. Clonal expansion of T cells in abdominal aortic aneurysm: a role for doxycycline as drug of choice? Kroon AM; Taanman JW Int J Mol Sci; 2015 May; 16(5):11178-95. PubMed ID: 25993290 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]